stone, are you seriously suggesting that if profit margins on pharmaceuticals were capped at, say, 15% that drug companies would no longer have an incentive to research and then produce new drugs?
Regardless of the merit of such a cap, I don't see how such a lucrative market would remain untapped.
i.e. they would make LESS but they would still make as much or more than most industries.
Regardless of the merit of such a cap, I don't see how such a lucrative market would remain untapped.
i.e. they would make LESS but they would still make as much or more than most industries.